Wyeth Teams with NIAID on HIV/AIDS Vaccines
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 67 (Table of Contents)
Published: 6 Jan-2006
DOI: 10.3833/pdr.v2006.i67.571 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Wyeth Pharmaceuticals and National Institute of Allergy and Infectious Diseases entered into agreement to develop and clinically evaluate adjuvant-enhanced plasmid DNA (pDNA) and peptide-based vaccines for treating HIV infections...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS